WVE Wave Life Sciences Ltd.
Wave Life Sciences Ltd. (WVE) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $67.2K.
Where they traded
Last open-market purchase: March 30, 2026 .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian | Director | Sell 10b5-1 | 12,700 | $5.29 | $67.2K | None left | |
| Wagner Heidi L | Director | Sell 10b5-1 | 7,000 | $6.01 | $42.1K | 44,930 −13.5% of holding | |
| TAKANASHI KEN | Director | Sell 10b5-1 | 3,864 | $6.01 | $23.2K | 20,079 −16.1% of holding | |
| Tan Aik Na | Director | Sell 10b5-1 | 432 | $6.01 | $2.6K | 24,968 −1.7% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.